DEF 14A
TEVA Misses on Q3 Earnings, Cuts 2022 Sales View, Stock Down | Nasdaq
Teva Reports Third Quarter 2020 Financial Results | Business Wire
TEVA PHARMACEUTICAL INDUSTRIES LIMITED : Stock Price | IL0006290147 | MarketScreener
Does Teva Pharmaceutical Industries (NYSE:TEVA) Have A Healthy Balance Sheet? | Nasdaq
Teva (TEVA) to Report Q1 Earnings: What's in the Cards?
Teva Reports First Quarter 2021 Financial Results | Business Wire
TEVA PHARMACEUTICAL INDUSTRIES LTD Form 10-Q Quarterly Report Filed 2021-07-28
Teva Pharmaceutical Industries Limited 2022 Q3 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Industries Limited 2022 Q3 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Teva shares rise as company offers reassurance on former flagship drug Copaxone - MarketWatch
Teva Stock: Teva Guides To Its First Year Of Growth Since 2017, But There's A Caveat | Investor's Business Daily
Opioid Manufacturer Teva Pharmaceuticals Reaches $4B Global Settlement | Law.com
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Analyst Ratings for Teva Pharmaceutical Indus | Markets Insider
Israel's TEVA, PERI Tank on Q4 Earnings; IZRL in Focus - TipRanks.com
Teva Pharmaceuticals Q2 2019 earnings preview | AlphaStreet
Teva is primed for a big bounce after years of underperformance, Barclays says
Teva Pharma Trends Lower Ahead Of A Key Shareholder Meeting This Week (NYSE: TEVA) | Seeking Alpha
Teva Reports Fourth Quarter and Full Year 2020 Financial Results | Business Wire
TEVA PHARMACEUTICAL INDUSTRIES LIMITED : TEVA Stock Price | US8816242098 | MarketScreener
Teva Ramps Up Sales With Medis, Respiratory Units - Bloomberg
Teva jumps after Wall Street upgrades, analysts say stock 'too cheap to ignore'
TEVA PHARMACEUTICAL INDUSTRIES LIMITED : TEVA Stock Quotes and Prices | US8816242098 | MarketScreener
